First-in-Human Study of ISH0688: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
ISH0688 is a human IgG1 Fc-FGF21 fusion protein. The objectives of the planned clinical investigation will be to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single- and multiple-ascending doses of ISH0688 via subcutaneous injection.
Epistemonikos ID: 4a244fb250e864d49406e7c5808d8fd8151312a8
First added on: Apr 02, 2026